AUY922 Completed Phase 1 Trials for Anaplastic Lymphoma Kinase (ALK) / Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01772797Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer